Retina Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-01-30
Clinical Trial Update: Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity [Phase 3]
Phase 3 trial comparing intravitreal ranibizumab for aggressive versus Type 1 prethreshold retinopathy of prematurity has completed.